Latest News about Health & Science
Recent news which mentions Health & Science
Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
February 13, 2024
From CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
February 13, 2024
From CNBC.com News
Defense Secretary Lloyd Austin re-hospitalized for bladder issue
February 11, 2024
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
February 10, 2024
From CNBC.com News
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
February 08, 2024
From CNBC.com News
From CNBC.com News
Healthy Returns: Novo Nordisk, Eli Lilly are tackling weight loss drug supply woes
February 06, 2024
From CNBC.com News
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
February 06, 2024
From CNBC.com News
Eli Lilly results blow past estimates on strong Zepbound launch, higher Mounjaro prices
February 06, 2024
From CNBC.com News
From CNBC.com News
Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch
February 02, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Neuralink competitor Synchron to ramp up brain implant production with equity stake in manufacturer
February 01, 2024
From CNBC.com News
From CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
January 31, 2024
From CNBC.com News
GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost
January 31, 2024
From CNBC.com News
Norway's giant wealth fund touts possibility of Novo Nordisk, Eli Lilly joining the trillion-dollar club
January 31, 2024
From CNBC.com News
From CNBC.com News
Vertex non-opioid painkiller shows positive results in critical late-stage trial on acute pain
January 30, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Pfizer beats earnings estimates as declining Covid business performs better than expected
January 30, 2024
From CNBC.com News
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
January 28, 2024
From CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
January 26, 2024
From CNBC.com News
Humana stock plunges on dismal 2024 forecast, as insurers face soaring medical costs
January 25, 2024
From CNBC.com News
Tyson Foods drops CVS for upstart pharmacy benefit manager, as industry upheaval over cost concerns spreads
January 24, 2024
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.